NCT01861314 2026-03-19Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1 Active not recruiting15 enrolled
NCT01303341 2026-03-18Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or MelanomaNational Cancer Institute (NCI)Phase 1 Active not recruiting35 enrolled